Amedisys, Inc.

Equities

AMED

US0234361089

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
90.4 USD -0.42% Intraday chart for Amedisys, Inc. -1.04% -4.90%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says MT
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says MT
RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating MT
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys RE
UnitedHealth Faces Antitrust Probe in US MT
Earnings Flash (AMED) AMEDISYS Reports Q4 EPS $0.94 MT
Amedisys, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Amedisys, Inc. Offers Advanced Molecular Testing to its Care Centers in Collaboration with Patient Choice Laboratories CI
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023. CI
Amedisys Q3 Adjusted Earnings, Net Service Revenue Decline MT
Earnings Flash (AMED) AMEDISYS Posts Q3 EPS $0.98 MT
Amedisys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating MT
Amedisys, Inc. Announces Management Changes CI
Deutsche Bank Adjusts Amedisys Price Target to $101 From $97, Maintains Buy Rating MT
Option Care Health Q2 Earnings, Revenue Increase MT
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023. CI
Earnings Flash (AMED) AMEDISYS Posts Q2 EPS $1.37 MT
Amedisys, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
North American Morning Briefing : Focus Fixed on -2- DJ
Jefferies Downgrades Amedisys to Hold From Buy, Adjusts Price Target to $101 From $98 MT
North American Morning Briefing : Claims Data, GDP -2- DJ
North American Morning Briefing : Chip Stocks Take -2- DJ
Benchmark Downgrades Amedisys to Hold From Buy MT
Investors don't know where to go Our Logo
Chart Amedisys, Inc.
More charts
Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
90.78 USD
Average target price
97.78 USD
Spread / Average Target
+7.71%
Consensus
  1. Stock Market
  2. Equities
  3. AMED Stock
  4. News Amedisys, Inc.
  5. Insider Trends: Insider Adds to Selling Trend at Amedisys